Intuitive Surgical, Inc. $ISRG Shares Purchased by ABN AMRO Bank N.V.

ABN AMRO Bank N.V. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 222.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 117,713 shares of the medical equipment provider’s stock after buying an additional 81,241 shares during the quarter. ABN AMRO Bank N.V.’s holdings in Intuitive Surgical were worth $52,002,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Norges Bank bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth $2,569,260,000. Rakuten Investment Management Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter valued at $388,436,000. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 2.1% during the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. Jennison Associates LLC raised its holdings in Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after buying an additional 528,359 shares during the period. Finally, Bessemer Group Inc. raised its holdings in Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after buying an additional 371,806 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.1%

NASDAQ:ISRG opened at $478.49 on Thursday. The firm has a market capitalization of $171.53 billion, a PE ratio of 60.65, a PEG ratio of 3.72 and a beta of 1.65. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The firm’s fifty day simple moving average is $553.29 and its 200 day simple moving average is $510.97.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.21 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ISRG shares. Daiwa Capital Markets boosted their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, January 17th. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, Citigroup reiterated a “neutral” rating and issued a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Insider Buying and Selling

In other news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 73,616 shares of company stock worth $40,929,575. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.